←Home

Medical Devices; Radiology Devices; Classification of the Radiological Machine Learning-Based Quantitative Imaging Software With Predetermined Change Control Plan

Federal Register US Published: 2026-06-17 00:00:00
Full text
The Food and Drug Administration (FDA) is classifying the radiological machine learning-based quantitative imaging software with predetermined change control plan into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the radiological machine learning-based quantitative imaging software with predetermined change control plan. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Recommended reads
U.S. Copyright Office Issues Notice of Inquiry on Music Streaming Fraud NewsNet 1095 October 7, 2026 The U.S. Copyright Office published a notice of inquiry (NOI) on music streaming fraud, pursuant to…
The NIST National Cybersecurity Center of Excellence (NCCoE) has released a summary of comments received on the Software and Agentic Artificial Intelligence (AI) Identity and Authorization concept pap…
NIST AI News · US 2026-09-29
Projects will address local cybersecurity workforce needs and will offer practical learning opportunities including internships, apprenticeships and hands-on projects.
NIST AI News · US 2026-09-18